FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne muscular dystrophy patients.
TRDA Stock Earnings: Entrada Therapeutics Beats EPS, Beats Revenue for Q2 2024 TRDA stock results show that Entrada Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
TRDA Stock Earnings: Entrada Therapeutics Beats EPS, Beats Revenue for Q1 2024 TRDA stock results show that Entrada Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Insiders Buying America's Car-Mart And 2 Other Stocks Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Sera Prognostics, Inc. (
NASDAQ: SERA ) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
Dow Jumps 150 Points; Crude Oil Rises 1% U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.
Nasdaq Edges Lower; Gold Rises 1.5% U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session Gainers IceCure Medical Ltd (
NASDAQ: ICCM ) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket Gainers IceCure Medical Ltd (
NASDAQ: ICCM ) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.
